FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006172567> ?p ?o ?g. }

• W2006172567 endingPage "431" @default.
• W2006172567 startingPage "427" @default.
• W2006172567 abstract "Although interferon-alfa (IFN-α) has proved effective in treating epidermotropic cutaneous T-cell lymphoma (ECTL), few studies have considered the follow-up of treated patients and whether complete remission was maintained. We studied 51 patients (one stage Ia, seven stage Ib, one stage IIa, 30 stage IIb, 11 stage III (Sézary syndrome) and one stage IV) who received low-dose IFN-α as monotherapy for ECTL (mean daily dose of IFN-α 2.7 × 106 units for 14.9 months), giving special consideration to the significance of My7 (CD13) antigen expression by epidermal basal cells in predicting the maintenance of complete remission. For a mean follow-up period of 43.4 months, the results showed 21 complete remissions, 13 partial remissions and 17 patients with stable or progressive disease. Twelve patients died during the follow-up (3–52 months). IFN-α led to an improved response in the early stages, with a greater number of complete remissions (P = 0.03) and partial remissions (P = 0.01). The mean time to complete remission was 4 months, regardless of clinical stage (P = 0.1). Of 21 patients in complete remission, 57% had a relapse within a mean period of 7.5 months. For patients maintained in complete remission, the mean period of response was 31 months. The length of complete remission was independent of clinical stage, and My7 antigen expression was not predictive of complete remission." @default.
• W2006172567 created "2016-06-24" @default.
• W2006172567 creator A5002644565 @default.
• W2006172567 creator A5004771280 @default.
• W2006172567 creator A5012569156 @default.
• W2006172567 creator A5012666922 @default.
• W2006172567 creator A5055244589 @default.
• W2006172567 date "1999-03-01" @default.
• W2006172567 modified "2023-09-25" @default.
• W2006172567 title "Long-term follow-up in 51 patients with mycosis fungoides and Sézary syndrome treated by interferon-alfa" @default.
• W2006172567 cites W1896729546 @default.
• W2006172567 cites W2013752963 @default.
• W2006172567 cites W2014464606 @default.
• W2006172567 cites W2016251911 @default.
• W2006172567 cites W2031429185 @default.
• W2006172567 cites W2032243824 @default.
• W2006172567 cites W2037438068 @default.
• W2006172567 cites W2047587804 @default.
• W2006172567 cites W2061320424 @default.
• W2006172567 cites W2084313057 @default.
• W2006172567 cites W2113798657 @default.
• W2006172567 cites W2128568150 @default.
• W2006172567 cites W2132464647 @default.
• W2006172567 cites W2157374060 @default.
• W2006172567 cites W2178301314 @default.
• W2006172567 cites W2412238736 @default.
• W2006172567 doi "https://doi.org/10.1046/j.1365-2133.1999.02704.x" @default.
• W2006172567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10233261" @default.
• W2006172567 hasPublicationYear "1999" @default.
• W2006172567 type Work @default.
• W2006172567 sameAs 2006172567 @default.
• W2006172567 citedByCount "82" @default.
• W2006172567 countsByYear W20061725672012 @default.
• W2006172567 countsByYear W20061725672013 @default.
• W2006172567 countsByYear W20061725672014 @default.
• W2006172567 countsByYear W20061725672015 @default.
• W2006172567 countsByYear W20061725672016 @default.
• W2006172567 countsByYear W20061725672017 @default.
• W2006172567 countsByYear W20061725672018 @default.
• W2006172567 countsByYear W20061725672019 @default.
• W2006172567 countsByYear W20061725672020 @default.
• W2006172567 countsByYear W20061725672021 @default.
• W2006172567 countsByYear W20061725672022 @default.
• W2006172567 countsByYear W20061725672023 @default.
• W2006172567 crossrefType "journal-article" @default.
• W2006172567 hasAuthorship W2006172567A5002644565 @default.
• W2006172567 hasAuthorship W2006172567A5004771280 @default.
• W2006172567 hasAuthorship W2006172567A5012569156 @default.
• W2006172567 hasAuthorship W2006172567A5012666922 @default.
• W2006172567 hasAuthorship W2006172567A5055244589 @default.
• W2006172567 hasConcept C126322002 @default.
• W2006172567 hasConcept C141071460 @default.
• W2006172567 hasConcept C142424586 @default.
• W2006172567 hasConcept C142724271 @default.
• W2006172567 hasConcept C146357865 @default.
• W2006172567 hasConcept C151730666 @default.
• W2006172567 hasConcept C203014093 @default.
• W2006172567 hasConcept C204787440 @default.
• W2006172567 hasConcept C2776178377 @default.
• W2006172567 hasConcept C2776434150 @default.
• W2006172567 hasConcept C2776694085 @default.
• W2006172567 hasConcept C2777756187 @default.
• W2006172567 hasConcept C2779338263 @default.
• W2006172567 hasConcept C2781228144 @default.
• W2006172567 hasConcept C2909179924 @default.
• W2006172567 hasConcept C3018657049 @default.
• W2006172567 hasConcept C3019096185 @default.
• W2006172567 hasConcept C71924100 @default.
• W2006172567 hasConcept C86803240 @default.
• W2006172567 hasConcept C87355193 @default.
• W2006172567 hasConcept C90924648 @default.
• W2006172567 hasConceptScore W2006172567C126322002 @default.
• W2006172567 hasConceptScore W2006172567C141071460 @default.
• W2006172567 hasConceptScore W2006172567C142424586 @default.
• W2006172567 hasConceptScore W2006172567C142724271 @default.
• W2006172567 hasConceptScore W2006172567C146357865 @default.
• W2006172567 hasConceptScore W2006172567C151730666 @default.
• W2006172567 hasConceptScore W2006172567C203014093 @default.
• W2006172567 hasConceptScore W2006172567C204787440 @default.
• W2006172567 hasConceptScore W2006172567C2776178377 @default.
• W2006172567 hasConceptScore W2006172567C2776434150 @default.
• W2006172567 hasConceptScore W2006172567C2776694085 @default.
• W2006172567 hasConceptScore W2006172567C2777756187 @default.
• W2006172567 hasConceptScore W2006172567C2779338263 @default.
• W2006172567 hasConceptScore W2006172567C2781228144 @default.
• W2006172567 hasConceptScore W2006172567C2909179924 @default.
• W2006172567 hasConceptScore W2006172567C3018657049 @default.
• W2006172567 hasConceptScore W2006172567C3019096185 @default.
• W2006172567 hasConceptScore W2006172567C71924100 @default.
• W2006172567 hasConceptScore W2006172567C86803240 @default.
• W2006172567 hasConceptScore W2006172567C87355193 @default.
• W2006172567 hasConceptScore W2006172567C90924648 @default.
• W2006172567 hasIssue "3" @default.
• W2006172567 hasLocation W20061725671 @default.
• W2006172567 hasLocation W20061725672 @default.
• W2006172567 hasOpenAccess W2006172567 @default.
• W2006172567 hasPrimaryLocation W20061725671 @default.
• W2006172567 hasRelatedWork W1990158591 @default.

• next